| 1 | Delayed Immunomodulation Improves Immune Dysfunction in a Murine Model of Pics. (Sengupta S, Alatrash N, Vaysburg D, Nomellini V) Shock 2026 Oct 01;66(4):1038-1044 |
| 1 | Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. (RECOVERY Collaborative Group) Lancet Child Adolesc Health 2024 Mar;8(3):190-200 35 Citations |
| 2 | Vaccines and use of immunosuppressive and immunomodulatory therapy in a pediatric dermatology clinic-A single institution experience. (Tran J, Trinh DL, Pan AY, Humphrey SR) Pediatr Dermatol 2023;40(4):644-646 |
| 2 | Sarcoma IL-12 overexpression facilitates NK cell immunomodulation. (Rademacher MJ, Cruz A, Faber M, Oldham RAA, Wang D, Medin JA, Schloemer NJ) Sci Rep 2021 Apr 15;11(1):8321 21 Citations |
| 1 | The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases. (Eshac Y, Redfern RL, Aakalu VK) Int J Mol Sci 2021 Jan 13;22(2) 18 Citations |
| 1 | Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles. (Barnes BJ, Somerville CC) Front Immunol 2020;11:1040 68 Citations |
| 1 | Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes. (Hesterberg RS, Beatty MS, Han Y, Fernandez MR, Akuffo AA, Goodheart WE, Yang C, Chang S, Colin CM, Alontaga AY, McDaniel JM, Mailloux AW, Billington JMR, Yue L, Russell S, Gillies RJ, Yun SY, Ayaz M, Lawrence NJ, Lawrence HR, Yu XZ, Fu J, Darville LN, Koomen JM, Ren X, Messina J, Jiang K, Garrett TJ, Rajadhyaksha AM, Cleveland JL, Epling-Burnette PK) Blood 2020 Aug 13;136(7):857-870 18 Citations |
| 1 | Immunomodulation in COVID-19. (Ingraham NE, Lotfi-Emran S, Thielen BK, Techar K, Morris RS, Holtan SG, Dudley RA, Tignanelli CJ) Lancet Respir Med 2020 Jun;8(6):544-546 143 Citations |
| 1 | Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. (Adashek JJ, Junior PNA, Galanina N, Kurzrock R) J Immunother Cancer 2019 May 22;7(1):130 7 Citations |
| 1 | Repeated lipopolysaccharide exposure leads to placental endotoxin tolerance. (Kim ML, Maloney C, Klimova N, Gurzenda E, Lin X, Arita Y, Walker T, Fazzari MJ, Hanna N) Am J Reprod Immunol 2019 Feb;81(2):e13080 11 Citations |
| 1 | Expression of TNF- and HNRNPL-related Immunoregulatory Long Non-coding RNA (THRIL) in Acute Myeloid Leukemia: Is There Any Correlation? (Sayad A, Hajifathali A, Omrani MD, Arsang-Jang S, Hamidieh AA, Taheri M) Iran J Allergy Asthma Immunol 2018 Jun;17(3):274-280 11 Citations |
| 1 | Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. (Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P, Djalilian AR) Stem Cells 2018 May;36(5):775-784 67 Citations |
| 1 | Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors. (Jardim DL, de Melo Gagliato D, Giles FJ, Kurzrock R) Clin Cancer Res 2018 Apr 15;24(8):1785-1794 46 Citations |
| 1 | Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels. (Guerra AD, Rose WE, Hematti P, Kao WJ) Acta Biomater 2017 Mar 15;51:184-196 29 Citations |
| 1 | T-cell programming in pancreatic adenocarcinoma: a review. (Seo YD, Pillarisetty VG) Cancer Gene Ther 2017 Mar;24(3):106-113 47 Citations |
| 1 | Differentiating Familial Neuropathies from Guillain-Barré Syndrome. (Bordini BJ, Monrad P) Pediatr Clin North Am 2017 Feb;64(1):231-252 5 Citations |
| 1 | Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT. (Ryan CE, Sahaf B, Logan AC, O'Brien S, Byrd JC, Hillmen P, Brown JR, Dyer MJ, Mato AR, Keating MJ, Jaglowski S, Clow F, Rezvani AR, Styles L, Coutre SE, Miklos DB) Blood 2016 Dec 22;128(25):2899-2908 67 Citations |
| 1 | Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. (Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, Leith C, Maroulakou I, Callander N, Miyamoto S, Hematti P, Apte SS, Asimakopoulos F) Blood 2016 Aug 04;128(5):680-5 139 Citations |
| 2 | Emerging immunotherapy in pediatric lymphoma. (Erker C, Harker-Murray P, Burke MJ) Future Oncol 2016 Jan;12(2):257-70 5 Citations |
| 1 | Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes. (Guerra AD, Cantu DA, Vecchi JT, Rose WE, Hematti P, Kao WJ) AAPS J 2015 May;17(3):620-30 17 Citations |
| 1 | A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. (Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, McKenna DH Jr, Gee AP, Lindblad R, Hei DJ, Hematti P) Cytotherapy 2015 Feb;17(2):140-51 81 Citations |
| 1 | Biomaterial-mesenchymal stem cell constructs for immunomodulation in composite tissue engineering. (Hanson S, D'Souza RN, Hematti P) Tissue Eng Part A 2014 Aug;20(15-16):2162-8 65 Citations |
| 1 | Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. (Goodrich AD, Varain NM, Jeanblanc CM, Colon DM, Kim J, Zanjani ED, Hematti P) Cytotherapy 2014 Sep;16(9):1280-93 8 Citations |
| 2 | Regulation of antiviral CD8 T-cell responses. (Kulinski JM, Tarakanova VL, Verbsky J) Crit Rev Immunol 2013;33(6):477-88 25 Citations |
| 1 | Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies. (Avigan D, Hari P, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Hsu KC) Biol Blood Marrow Transplant 2013 Dec;19(12):1661-9 11 Citations |
| 2 | Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. (Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis VA, Steward C, Wagner JE, Carpenter PA, Eapen M) Blood 2012 Jun 21;119(25):6155-61 42 Citations |
| 1 | Photobiomodulation protects the retina from light-induced photoreceptor degeneration. (Albarracin R, Eells J, Valter K) Invest Ophthalmol Vis Sci 2011 Jun 01;52(6):3582-92 136 Citations |
| 1 | Human embryonic stem cell-derived mesenchymal progenitors: an overview. (Hematti P) Methods Mol Biol 2011;690:163-74 37 Citations |
| 1 | Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 5 Citations |
© 2026 Clinical & Translational Science Institute